An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer

[1]  E. Skarpen,et al.  Isolation and mass spectrometry analysis of urinary extraexosomal proteins , 2016, Scientific Reports.

[2]  G. Steinberg.  Blue Light Cystoscopy Should be Used Routinely for Bladder Cancer Detection: Pro. , 2016, The Journal of urology.

[3]  Conghui Han,et al.  ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis , 2016, Oncology letters.

[4]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[5]  Utkan Demirci,et al.  Advances in addressing technical challenges of point-of-care diagnostics in resource-limited settings , 2016, Expert review of molecular diagnostics.

[6]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[7]  Emily B Hanhauser,et al.  Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics , 2015, Proceedings of the National Academy of Sciences.

[8]  P. Chaves,et al.  Urinary uromodulin, kidney function and cardiovascular disease in elderly adults , 2015, Kidney international.

[9]  Xiao-Fan Wang,et al.  A niche role for cancer exosomes in metastasis , 2015, Nature Cell Biology.

[10]  Hadi Shafiee,et al.  Portable Microfluidic Integrated Plasmonic Platform for Pathogen Detection , 2015, Scientific Reports.

[11]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[12]  Y. Lotan,et al.  Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus , 2014, Urologia Internationalis.

[13]  D. Hawke,et al.  Benchtop isolation and characterization of functional exosomes by sequential filtration. , 2014, Journal of chromatography. A.

[14]  B. Roizman,et al.  Cells infected with herpes simplex virus 1 export to uninfected cells exosomes containing STING, viral mRNAs, and microRNAs , 2014, Proceedings of the National Academy of Sciences.

[15]  Diane M Simeone,et al.  Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. , 2014, Lab on a chip.

[16]  Yusuke Yoshioka,et al.  Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen , 2014, Nature Communications.

[17]  Francoise F Giguel,et al.  Micro-a-fluidics ELISA for Rapid CD4 Cell Count at the Point-of-Care , 2014, Scientific Reports.

[18]  A. Godwin,et al.  Lab on a Chip Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology †‡ , 2014 .

[19]  M. Babjuk,et al.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. , 2013, European urology.

[20]  P. Nietert,et al.  Evaluation of urovysion and cytology for bladder cancer detection , 2013, Cancer cytopathology.

[21]  Amit Singhal,et al.  Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics. , 2013, Biotechnology advances.

[22]  Savas Tasoglu,et al.  Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood. , 2013, ACS nano.

[23]  Francoise F Giguel,et al.  Simple filter microchip for rapid separation of plasma and viruses from whole blood , 2012, International journal of nanomedicine.

[24]  S. Goodison,et al.  Urinary BTA: indicator of bladder cancer or of hematuria , 2012, World Journal of Urology.

[25]  Utkan Demirci,et al.  Efficient on-chip isolation of HIV subtypes. , 2012, Lab on a chip.

[26]  W. Qiu,et al.  Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care. , 2011, Lab on a chip.

[27]  Hamid Cheshmi.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[28]  F. Scolari,et al.  The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. , 2011, Kidney international.

[29]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .

[30]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[31]  M. Knowles,et al.  Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. , 2010, Urologic oncology.

[32]  P. Fernández-Llama,et al.  Tamm-Horsfall protein and urinary exosome isolation. , 2010, Kidney international.

[33]  Rong-Fong Shen,et al.  Identification and proteomic profiling of exosomes in human urine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Ozen.  Bladder cancer. , 1998, Current opinion in oncology.

[35]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.